首页> 外文会议>IEEE International Conference on Computational Advances in Bio and Medical Sciences >Poster: Classifying primary outcomes in rheumatoid arthritis: Knowledge discovery from clinical trial metadata
【24h】

Poster: Classifying primary outcomes in rheumatoid arthritis: Knowledge discovery from clinical trial metadata

机译:海报:分类类风湿性关节炎的主要结果:临床试验元数据的知识发现

获取原文

摘要

Early prediction of treatment outcomes in RA clinical trials is critical for both patient safety and trial success. We hypothesize that an approach employing metadata of clinical trials could provide accurate classification of primary outcomes before trial implementation. We retrieved RA clinical trials metadata from ClinicalTrials.gov. Four quantitative outcome measures that are frequently used in RA trials, i.e., ACR20, DAS28, and AE/SAE, were the classification targets in the model. Classification rules were applied to make the prediction and were evaluated. The results confirmed our hypothesis. We concluded that the metadata in clinical trials could be used to make early prediction of the study outcomes with acceptable accuracy.
机译:RA临床试验中治疗结果的早期预测对于患者安全和审判成功至关重要。我们假设采用临床试验元数据的方法可以在试验之前提供准确分类初级结果。我们从ClinCORICLTIALS.GOV中检索RA临床试验元数据。常用于RA试验的四种定量结果测量,即ACR20,DAS28和AE / SAE是模型中的分类目标。分类规则被应用于进行预测并进行评估。结果证实了我们的假设。我们得出结论,临床试验中的元数据可用于以可接受的准确性提高研究结果的早期预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号